NEWS BY TAG: Pharmaceuticals Subscribe
NuPathe: A Simple Approach to a Complex Medical Problem
What does it take to shake up a complex, highly regulated industry? A visionary with single-minded purpose. Many would balk at taking on the pharmaceutical establishment, but neuroscientist Jane Hollingsworth met the challenge head-on. With a simple approach to a complex industry, Hollingsworth came up Read More...
Forum for Regenerative Medicine Companies Seeking Capital to Be Held April 2010
The April 2010 Translational Forum is the only regenerative medicine conference globally that features investor funding and business model panels followed by a venture forum designed specifically for industry. Additionally, the Translational Forum will include participation from executives from more than 30 companies that have Read More...
BFTP-Funded Company, NuPathe, Helps Migranine Sufferers
The 30 million Americans who get migraines know they are more than just headaches. They affect work & family life. For many, finding relief is difficult. But there is a new remedy on the way. It’s a local company with a new twist on an Read More...
Immunotope: New Vaccine Stops Cancer Cells from Reproducing
Preventing cancer from recurring after surgery and chemotherapy is one of the keys to successful long-term patient care and survival. But while surgery and other treatments for late-stage cancer greatly reduce tumors, they’re not typically effective in eliminating the very small numbers of cancer cells Read More...
Saladax Biomedical: Making Chemotherapy Safer and More Effective for Cancer Patients
Individuals metabolize anti-cancer drugs at dramatically different rates, leading to as much as a 50-fold difference in the concentration of the medicine in the bloodstream of different patients even when identical doses are administered. This can lead to severe toxicity, illness or even death. Sal Read More...
Applied Computational Technologies: Improving Radiation Therapy for Cancer Patients
What started as a conversation in church between two new members may change the face of radiation treatment forever. Engineer Andy Holland had an idea for a new way to improve radiation therapy but knew he didn’t have the business experience to get it going. Read More...
Othera: Dropping the Leading Causes of Blindness
As the first wave of Baby Boomers turns 60 this year, an estimated 35 million people are poised to develop vision-debilitating cataracts. Exton-based Othera Pharmaceuticals believes that’s 35 million people too many. Othera is a specialty pharmaceutical company developing innovative drugs to treat and Read More...
Azevan Targets Stress-Related Illnesses and Congestive Heart Failure
Developing next-generation drugs for the treatment of central nervous system disorders and cardiovascular disease is a long and costly process. Azevan Pharmaceuticals, a Bethlehem-based early-stage company, believes the way to get there is through strategic partnerships. Azevan’s strategy is tied to the evolving nature Read More...
Biosyn Brings New Jobs to the Region, Hope to the Third World
Biosyn Inc., a Huntingdon Valley biotechnology company whose main product could help stem the AIDS epidemic, is staying put. Almost a year after being purchased by California-based Cellegy Pharmaceuticals Inc., the company has decided to relocate its corporate headquarters – including senior management and research Read More...
Digestive Care’s Innovative Medicine for Cystic Fibrosis Finds New Markets
Dr. Tibor Sipos knows the value of niche marketing. Fifteen years ago he left his position as director of dental research at Johnson & Johnson to form Digestive Care, Inc. His goal: to develop a much-needed cystic fibrosis medicine – one the pharmaceutical giants wouldn’t Read More...
